Prevention of muscle disuse atrophy by MG132 proteasome inhibitor
- 1 April 2011
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 43 (5) , 708-715
Abstract
Introduction: Our goal was to determine whether in vivo administration of the proteasome inhibitor MG132 can prevent muscle atrophy caused by hindlimb unloading (HU). Methods: Twenty‐seven NMRI mice were assigned to a weight‐bearing control, a 6‐day HU, or a HU+MG132 (1 mg/kg/48 h) treatment group. Results: Gastrocnemius wasting was significantly less in HU+MG132 mice (−6.7 ± 2.0%) compared with HU animals (−12.6 ± 1.1%, P = 0.011). HU was also associated with an increased expression of MuRF‐1 (P = 0.006), MAFbx (P = 0.001), and USP28 (P = 0.027) mRNA, whereas Nedd4, E3α, USP19, and UBP45 mRNA did not change significantly. Increases in MuRF‐1, MAFbx, and USP28 mRNA were largely repressed after MG132 administration. β5 proteasome activity tended to increase in HU (+16.7 ± 6.1%, P = 0.086). Neither β1 and β2 proteasome activities nor ubiquitin‐conjugated proteins were changed by HU. Conclusions: Our results indicate that in vivo administration of MG132 partially prevents muscle atrophy associated with disuse and highlight an unexpected regulation of MG132 proteasome inhibitor on ubiquitin‐ligases. Muscle Nerve, 2011Keywords
This publication has 37 references indexed in Scilit:
- Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligasesMuscle & Nerve, 2010
- Effect of flywheel-based resistance exercise on processes contributing to muscle atrophy during unloading in adult ratsJournal of Applied Physiology, 2006
- Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathwayJournal of Applied Physiology, 2005
- Response of the ubiquitin-proteasome pathway to changes in muscle activityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic statesAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Effects of proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on protein metabolism in septic ratsInternational Journal of Experimental Pathology, 2004
- The role of ubiquitin–proteasome-dependent proteolysis in the remodelling of skeletal muscleProceedings of the Nutrition Society, 2004
- Proteasome Inhibitor (MG-132) Treatment of mdx Mice Rescues the Expression and Membrane Localization of Dystrophin and Dystrophin-Associated ProteinsThe American Journal of Pathology, 2003
- Identification of Ubiquitin Ligases Required for Skeletal Muscle AtrophyScience, 2001
- Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.Journal of Clinical Investigation, 1997